As patients increasingly turn to cannabis for chronic pain, clinicians grapple with mixed evidence and a lack of high-quality ...

The human cannabinoid 1 receptor (hCB1), a ubiquitous G protein-coupled receptor (GPCR), transmits cannabinergic signals that participate in diverse (patho)physiological processes. Pharmacotherapeutic ...

Scientists have discovered novel drug candidates which could ultimately lead to new effective treatments for conditions ...

Exhale Wellness officially announced two new strains in its THCA flower collection for 2025 - Skywalker OG and Sunset Sherbet. Read more details.

Exhale Wellness launches its new line of Delta 9 Gummies - Bottle Caps. Learn about the product - ingredients, flavors, lab ...

An Ozempic-like drug prescribed for diabetes has been found to reduce the frequency of debilitating migraine. Researchers say liraglutide, a GLP-1RA, might help migraine by reducing intracranial ...

New research published in the European Journal of Pharmacology found that THC and CBD—especially when combined in equal parts ...

MIRA is advancing complementary non-opioid therapies for two of the largest pain markets MIAMI, FLORIDA / ACCESS Newswire / ...

Cannabidiolic acid (CBDA), a minor non-psychoactive cannabinoid, has demonstrated greater neuroprotective effects than ...

New research reveals that daily low-dose cannabis use can preserve and enhance working memory in adults over 65. (Working ...

Even daily use of low-level cannabis does not have a negative impact on cognition in older adults, recent research finds.

This study overall shows there is an interplay between the BBB and CB1 receptors on perivascular astrocytes that influences chronic stress resilience.